Intercept Pharma up 30% on report of possible sale
Intercept Pharmaceuticals, a biotechnology company, is exploring a possible sale, according to Reuters sources.
Intercept Pharmaceuticals, a biotechnology company, is exploring a possible sale, according to Reuters sources.